IDC’s Bob Parker and Simon Ellis share groundbreaking research on how ongoing supply chain disruptions caused by COVID-19 are impacting the pharmaceutical industry. They also offer expert tips on how to adopt a holistic view of the end-to-end supply chain, achieve greater agility, and boost supply chain resiliency.

• Gaining end-to-end supply chain visibility alone is not enough. You also need the ability to rapidly intervene and adapt to new conditions when supply chain disruptions are spotted.
• Pharma supply chain companies should consider creating a decision environment that serves as a “process twin,” enabling them to quickly identify root causes and rectify adverse events in the supply chain.
• Companies should stop deploying local or siloed solutions to fix problems. It’s time to do away with the “metaphorical Band-aids” and start thinking holistically about how to achieve supply chain resiliency.
• The Agile-Supply Chain Credo is a set of guiding principles for transforming your supply chain and achieving real patient-centricity.